Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Central Nervous System (CNS) Metastases
Interventions: DRUG: Lapatinib in Tandem With Capecitabine
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Queens Cancer Center of Queens Hospital|University of Michigan